Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP71510.RAKxbHg3yDNdjlCMAnkrZDAOytkGnmvUd1A9hF_LtcWH0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP71510.RAKxbHg3yDNdjlCMAnkrZDAOytkGnmvUd1A9hF_LtcWH0130_assertion type Assertion NP71510.RAKxbHg3yDNdjlCMAnkrZDAOytkGnmvUd1A9hF_LtcWH0130_head.
- NP71510.RAKxbHg3yDNdjlCMAnkrZDAOytkGnmvUd1A9hF_LtcWH0130_assertion description "[Given that the identical somatic activating mutation in the JAK2 tyrosine kinase gene (JAK2(V617F)) is observed in most individuals with polycythemia vera, essential thrombocythemia and primary myelofibrosis, there likely are additional genetic events that contribute to the pathogenesis of these phenotypically distinct disorders.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP71510.RAKxbHg3yDNdjlCMAnkrZDAOytkGnmvUd1A9hF_LtcWH0130_provenance.
- NP71510.RAKxbHg3yDNdjlCMAnkrZDAOytkGnmvUd1A9hF_LtcWH0130_assertion evidence source_evidence_literature NP71510.RAKxbHg3yDNdjlCMAnkrZDAOytkGnmvUd1A9hF_LtcWH0130_provenance.
- NP71510.RAKxbHg3yDNdjlCMAnkrZDAOytkGnmvUd1A9hF_LtcWH0130_assertion SIO_000772 19287384 NP71510.RAKxbHg3yDNdjlCMAnkrZDAOytkGnmvUd1A9hF_LtcWH0130_provenance.
- NP71510.RAKxbHg3yDNdjlCMAnkrZDAOytkGnmvUd1A9hF_LtcWH0130_assertion wasDerivedFrom gad-20130706 NP71510.RAKxbHg3yDNdjlCMAnkrZDAOytkGnmvUd1A9hF_LtcWH0130_provenance.
- NP71510.RAKxbHg3yDNdjlCMAnkrZDAOytkGnmvUd1A9hF_LtcWH0130_assertion wasGeneratedBy ECO_0000203 NP71510.RAKxbHg3yDNdjlCMAnkrZDAOytkGnmvUd1A9hF_LtcWH0130_provenance.